TIANAN MEDICARE (00383) expects a profit alert, anticipating a mid-term profit attributable to shareholders of approximately HKD 30 million to HKD 60 million.

TIANAN MEDICARE (00383) announced that the group expects to record a shareholders' profit attributable to equity holders of approximately HKD 30 million to HKD 60 million for the six months ended June 30, 2026, compared to a shareholders' profit of about HKD 12 million for the six months ended June 30, 2025. This is mainly due to (i) an increase in operating revenue from the medical segment; (ii) a decrease in non-cash fair value losses on investment properties; (iii) an increase in fair value gains on trading investments; but partially offset by (iv) a decrease in net foreign exchange gains for the first half of 2025.